$XOS
Xos, Inc. Stock $xos

$xos Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000181949322000013 Filed on March 30, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$3.302M	$5.048M	$943.0K
YoY Change	250.16%	91.14%
Cost Of Revenue	$5.735M	$7.410M	$702.0K
YoY Change	716.95%	216.53%
Gross Profit	-$2.433M	-$2.362M	$241.0K
YoY Change	-1109.54%	-887.33%
Gross Profit Margin	-73.68%	-46.79%	25.56%
Selling, General & Admin	$10.44M	$30.72M	$3.035M
YoY Change	243.86%	495.62%
% of Gross Profit			1259.34%
Research & Development	$13.21M	$20.08M	$2.140M
YoY Change	517.29%	186.2%
% of Gross Profit			887.97%
Depreciation & Amortization	$108.0K	$736.0K	$148.0K
YoY Change	-27.03%	148.65%
% of Gross Profit			61.41%
Operating Expenses	$23.02M	$50.79M	$5.254M
YoY Change	338.1%	317.29%
Operating Profit	-$25.45M	-$53.16M	-$5.013M
YoY Change	407.7%	347.73%
Interest Expense	$12.58M	$18.54M	-$2.609M
YoY Change	-582.33%	-486.57%
% of Operating Profit
Other Income/Expense, Net	$24.31M	$38.00K	-$4.000K
YoY Change	-607800.0%	-101.16%
Pretax Income	$11.44M	$23.40M	-$7.626M
YoY Change	-250.03%	-240.42%
Income Tax	$2.000K	$2.000K
% Of Pretax Income	0.02%	0.01%
Net Earnings	$11.44M	$23.40M	-$7.626M
YoY Change	-250.0%	-240.4%
Net Earnings / Revenue	346.43%	463.57%	-808.7%
Basic Earnings Per Share		$0.22
Diluted Earnings Per Share	$69.88K	$0.22	-$47.02K
COMMON SHARES
Basic Shares Outstanding	162.9M shares	105.6M shares
Diluted Shares Outstanding		107.8M shares

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$110.8M	$113.6M	$10.36M
YoY Change	969.97%	996.83%
Cash & Equivalents	$16.14M	$16.14M	$10.36M
Short-Term Investments	$94.70M	$97.48M	$0.00
Other Short-Term Assets	$18.10M	$18.10M	$0.00
YoY Change		32223.21%
Inventory	$30.88M	$30.88M	$1.867M
Prepaid Expenses
Receivables	$3.353M	$3.353M	$408.0K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$166.0M	$166.0M	$12.69M
YoY Change	1207.79%	1207.79%
LONG-TERM ASSETS
Property, Plant & Equipment	$7.426M	$7.426M	$1.084M
YoY Change	585.06%	585.06%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$54.82M	$54.82M
YoY Change
Other Assets	$506.0K	$506.0K	$0.00
YoY Change
Total Long-Term Assets	$62.75M	$62.75M	$1.084M
YoY Change	5688.56%	5688.56%
TOTAL ASSETS
Total Short-Term Assets	$166.0M	$166.0M	$12.69M
Total Long-Term Assets	$62.75M	$62.75M	$1.084M
Total Assets	$228.7M	$228.7M	$13.77M
YoY Change	1560.42%	1560.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$10.12M	$10.12M	$1.168M
YoY Change	766.61%	766.61%
Accrued Expenses	$4.303M	$3.997M	$1.837M
YoY Change	134.24%	36.84%
Deferred Revenue	$899.0K		$731.0K
YoY Change	22.98%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$482.0K	$482.0K
YoY Change		-97.39%
Total Short-Term Liabilities	$15.98M	$15.98M	$32.94M
YoY Change	-51.48%	-51.48%
LONG-TERM LIABILITIES
Long-Term Debt	$1.594M	$1.594M
YoY Change		860.24%
Other Long-Term Liabilities	$36.74M	$36.74M
YoY Change
Total Long-Term Liabilities	$38.33M	$38.33M
YoY Change		22990.36%
TOTAL LIABILITIES
Total Short-Term Liabilities	$15.98M	$15.98M	$32.94M
Total Long-Term Liabilities	$38.33M	$38.33M
Total Liabilities	$54.31M	$54.31M	$33.11M
YoY Change	64.04%	64.04%
SHAREHOLDERS EQUITY
Retained Earnings	-$4.093M		-$27.49M
YoY Change	-85.11%
Common Stock	$16.00K		$7.000K
YoY Change	128.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$174.4M	$174.4M	-$27.20M
YoY Change
Total Liabilities & Shareholders Equity	$228.7M	$228.7M	$13.77M
YoY Change	1560.42%	1560.42%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	$11.44M	$23.40M	-$7.626M
YoY Change	-250.0%	-240.4%
Depreciation, Depletion And Amortization	$108.0K	$736.0K	$148.0K
YoY Change	-27.03%	148.65%
Cash From Operating Activities	-$35.76M	-$88.90M	-$8.298M
YoY Change	330.95%	620.5%
INVESTING ACTIVITIES
Capital Expenditures	-$1.572M	$4.915M	-$264.0K
YoY Change	495.45%	1107.62%
Acquisitions
YoY Change
Other Investing Activities	-$150.2M	-$150.2M
YoY Change
Cash From Investing Activities	-$151.8M	-$155.1M	-$264.0K
YoY Change	57400.0%	38018.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-652.0K	$252.9M	10.05M
YoY Change	-106.49%	995.32%
NET CHANGE
Cash From Operating Activities	-35.76M	-$88.90M	-8.298M
Cash From Investing Activities	-151.8M	-$155.1M	-264.0K
Cash From Financing Activities	-652.0K	$252.9M	10.05M
Net Change In Cash	-188.2M	$8.817M	1.487M
YoY Change	-12757.16%	-14.73%
FREE CASH FLOW
Cash From Operating Activities	-$35.76M	-$88.90M	-$8.298M
Capital Expenditures	-$1.572M	$4.915M	-$264.0K
Free Cash Flow	-$34.19M	-$93.81M	-$8.034M
YoY Change	325.54%	636.05%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001819493
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	001-39598
CY2021	dei	Entity Registrant Name EntityRegistrantName	XOS, INC.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1550505
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	3550 Tyburn Street
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Los Angeles
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90065
CY2021	dei	City Area Code CityAreaCode	818
CY2021	dei	Local Phone Number LocalPhoneNumber	316-1890
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	true
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2021	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2021	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	163234485	shares
CY2021Q2	dei	Entity Public Float EntityPublicFloat	372750000	USD
CY2021	dei	Auditor Name AuditorName	WithumSmith+Brown, PC
CY2021	dei	Auditor Location AuditorLocation	Irvine, California
CY2021	dei	Auditor Firm AuditorFirmId	100
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16142000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10359000	USD
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	3034000	USD
CY2020Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3353000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	408000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	94696000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	0	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	30883000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	1867000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	17850000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	56000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	165958000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	12690000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7426000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1084000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	54816000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	0	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	506000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	0	USD
CY2021Q4	us-gaap	Assets Assets	228706000	USD
CY2020Q4	us-gaap	Assets Assets	13774000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	10122000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1168000	USD
CY2021Q4	us-gaap	Loans Payable Current LoansPayableCurrent	482000	USD
CY2020Q4	xos	Warrants And Rights Outstanding Current WarrantsAndRightsOutstandingCurrent	1707000	USD
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5379000	USD
CY2020Q4	us-gaap	Loans Payable Current LoansPayableCurrent	142000	USD
CY2021Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	0	USD
CY2020Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	18360000	USD
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	USD
CY2020Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	6394000	USD
CY2021Q4	xos	Simple Agreement For Future Equity Notes Payable Current SimpleAgreementForFutureEquityNotesPayableCurrent	0	USD
CY2020Q4	xos	Simple Agreement For Future Equity Notes Payable Current SimpleAgreementForFutureEquityNotesPayableCurrent	30000	USD
CY2021Q4	xos	Warrants And Rights Outstanding Current WarrantsAndRightsOutstandingCurrent	0	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5142000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	15983000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	32943000	USD
CY2021Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	1594000	USD
CY2020Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	166000	USD
CY2021Q4	xos	Derivative Instrument Contingent Consideration Liability DerivativeInstrumentContingentConsiderationLiability	29240000	USD
CY2020Q4	xos	Derivative Instrument Contingent Consideration Liability DerivativeInstrumentContingentConsiderationLiability	0	USD
CY2021Q4	xos	Warrants And Rights Outstanding Noncurrent WarrantsAndRightsOutstandingNoncurrent	7496000	USD
CY2020Q4	xos	Warrants And Rights Outstanding Noncurrent WarrantsAndRightsOutstandingNoncurrent	0	USD
CY2021Q4	us-gaap	Liabilities Liabilities	54313000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	33109000	USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	27041000	shares
CY2020Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	27041000	shares
CY2021Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	0	shares
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2020Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	2762000	shares
CY2020Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	2762000	shares
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	USD
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	7862000	USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	163137000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	163137000	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	72277000	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	72277000	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	16000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	7000	USD
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	178851000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	290000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4093000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-27494000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-381000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	174393000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-27197000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	228706000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13774000	USD
CY2021	us-gaap	Revenues Revenues	5048000	USD
CY2020	us-gaap	Revenues Revenues	2641000	USD
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	7410000	USD
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	2341000	USD
CY2021	us-gaap	Gross Profit GrossProfit	-2362000	USD
CY2020	us-gaap	Gross Profit GrossProfit	300000	USD
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	27197000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3609000	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	20077000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7015000	USD
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3519000	USD
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1548000	USD
CY2021	us-gaap	Operating Expenses OperatingExpenses	50793000	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	12172000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-53155000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-11872000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	38000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3285000	USD
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	18498000	USD
CY2020	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-1510000	USD
CY2021	xos	Derivative Instrument Change In Amount Of Contingent Consideration Liability DerivativeInstrumentChangeInAmountOfContingentConsiderationLiability	-72505000	USD
CY2020	xos	Derivative Instrument Change In Amount Of Contingent Consideration Liability DerivativeInstrumentChangeInAmountOfContingentConsiderationLiability	0	USD
CY2021	xos	Write Off Of Shares Subscribed But Unissued Subscriptions Receivable WriteOffOfSharesSubscribedButUnissuedSubscriptionsReceivable	379000	USD
CY2020	xos	Write Off Of Shares Subscribed But Unissued Subscriptions Receivable WriteOffOfSharesSubscribedButUnissuedSubscriptionsReceivable	0	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-14104000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	23403000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16667000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	23401000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-16667000	USD
CY2021	us-gaap	Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent	0	USD
CY2021	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax	-381000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax	0	USD
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.22
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	23020000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-16667000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.22
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	105568000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	72027000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	107786000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	72027000	shares
CY2019Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2019Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-10534000	USD
CY2020	xos	Temporary Equity Stock Issued During Period Shares New Issues TemporaryEquityStockIssuedDuringPeriodSharesNewIssues	2762000	shares
CY2020	us-gaap	Temporary Equity Stock Issued During Period Value New Issues TemporaryEquityStockIssuedDuringPeriodValueNewIssues	9570000	USD
CY2020	xos	Temporary Equity Stock Issued During Period Value Warrants TemporaryEquityStockIssuedDuringPeriodValueWarrants	-1708000	USD
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	7000	USD
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	1004000	USD
CY2020	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	3000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	15000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-16667000	USD
CY2020Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	2762000	shares
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	7862000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-27197000	USD
CY2021	xos	Temporary Equity Shares Subscribed But Unissued Subscriptions Receivable Payment TemporaryEquitySharesSubscribedButUnissuedSubscriptionsReceivablePayment	2430000	USD
CY2021	xos	Adjustments To Additional Paid In Capital Payment Of Temporary Equity Subscription Receivable AdjustmentsToAdditionalPaidInCapitalPaymentOfTemporaryEquitySubscriptionReceivable	379000	USD
CY2021	xos	Temporary Equity Stock Issued During Period Shares New Issues TemporaryEquityStockIssuedDuringPeriodSharesNewIssues	49518000	shares
CY2021	us-gaap	Temporary Equity Stock Issued During Period Value New Issues TemporaryEquityStockIssuedDuringPeriodValueNewIssues	66701000	USD
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	11000	USD
CY2021	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	1000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1658000	USD
CY2021	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	335000	USD
CY2021	xos	Temporary Equity Stock Issued During Period Shares Preferred Stock Warrant Exercised TemporaryEquityStockIssuedDuringPeriodSharesPreferredStockWarrantExercised	625000	shares
CY2021	xos	Temporary Equity Stock Issued During Period Value Preferred Stock Warrant Exercised TemporaryEquityStockIssuedDuringPeriodValuePreferredStockWarrantExercised	2715000	USD
CY2021	xos	Temporary Equity Stock Issued During Period Shares Conversion Of Convertible Securities TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	-52905000	shares
CY2021	xos	Temporary Equity Stock Issued During Period Value Conversion Of Convertible Securities TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities	-79708000	USD
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	79772000	USD
CY2021	xos	Reverse Recapitalization Transaction Costs ReverseRecapitalizationTransactionCosts	55424000	USD
CY2021	xos	Stock Issued During Period Value Reverse Recapitalization StockIssuedDuringPeriodValueReverseRecapitalization	20721000	USD
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	196000000	USD
CY2021	xos	Adjustments To Additional Paid In Capital Warrants Recognized In Reverse Recapitalization AdjustmentsToAdditionalPaidInCapitalWarrantsRecognizedInReverseRecapitalization	17891000	USD
CY2021	xos	Adjustments To Additional Paid In Capital Recognition Of Derivative Instrument Contingent Consideration Liability AdjustmentsToAdditionalPaidInCapitalRecognitionOfDerivativeInstrumentContingentConsiderationLiability	101744000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	23020000	USD
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	174393000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	23401000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-16667000	USD
CY2021	us-gaap	Depreciation Depreciation	736000	USD
CY2020	us-gaap	Depreciation Depreciation	296000	USD
CY2020	us-gaap	Paid In Kind Interest PaidInKindInterest	1712000	USD
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2021	us-gaap	Paid In Kind Interest PaidInKindInterest	0	USD
CY2021	xos	Write Off Of Shares Subscribed But Unissued Subscriptions Receivable WriteOffOfSharesSubscribedButUnissuedSubscriptionsReceivable	379000	USD
CY2020	xos	Write Off Of Shares Subscribed But Unissued Subscriptions Receivable WriteOffOfSharesSubscribedButUnissuedSubscriptionsReceivable	0	USD
CY2021	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	-14104000	USD
CY2020	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	0	USD
CY2021	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	18498000	USD
CY2020	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-1510000	USD
CY2021	xos	Derivative Instrument Change In Amount Of Contingent Consideration Liability DerivativeInstrumentChangeInAmountOfContingentConsiderationLiability	-72505000	USD
CY2020	xos	Derivative Instrument Change In Amount Of Contingent Consideration Liability DerivativeInstrumentChangeInAmountOfContingentConsiderationLiability	0	USD
CY2021	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	1000	USD
CY2020	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	0	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	1658000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	12000	USD
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-364000	USD
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	16000	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2973000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	229000	USD
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	17794000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	41000	USD
CY2021	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	506000	USD
CY2020	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	0	USD
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	29969000	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	297000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	9009000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-310000	USD
CY2021	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	2696000	USD
CY2020	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	1692000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-88895000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12338000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4915000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	407000	USD
CY2021	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	152651000	USD
CY2020	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	0	USD
CY2021	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	2423000	USD
CY2020	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	0	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-155143000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-407000	USD
CY2021	xos	Proceeds From Reverse Recapitalization ProceedsFromReverseRecapitalization	20721000	USD
CY2020	xos	Proceeds From Reverse Recapitalization ProceedsFromReverseRecapitalization	0	USD
CY2021	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	196000000	USD
CY2020	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	USD
CY2021	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock	31757000	USD
CY2020	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock	9570000	USD
CY2021	xos	Proceeds From Collection Of Temporary Equity Subscription Receivable ProceedsFromCollectionOfTemporaryEquitySubscriptionReceivable	2430000	USD
CY2020	xos	Proceeds From Collection Of Temporary Equity Subscription Receivable ProceedsFromCollectionOfTemporaryEquitySubscriptionReceivable	0	USD
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
CY2020	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	13440000	USD
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	2715000	USD
CY2020	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
CY2021	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	0	USD
CY2020	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	190000	USD
CY2021	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	444000	USD
CY2020	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	152000	USD
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	11000	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	10000	USD
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	335000	USD
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2021	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	USD
CY2020	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	30000	USD
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	252855000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	23085000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	8817000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	10340000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10359000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19176000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10359000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16142000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10359000	USD
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	3034000	USD
CY2020Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19176000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10359000	USD
CY2021	xos	Debt Conversion Converted Instrument Interest Payable Amount DebtConversionConvertedInstrumentInterestPayableAmount	2453000	USD
CY2020	xos	Debt Conversion Converted Instrument Interest Payable Amount DebtConversionConvertedInstrumentInterestPayableAmount	0	USD
CY2021	xos	Fair Value Adjustment Of Related Party Debt At Conversion FairValueAdjustmentOfRelatedPartyDebtAtConversion	3763000	USD
CY2020	xos	Fair Value Adjustment Of Related Party Debt At Conversion FairValueAdjustmentOfRelatedPartyDebtAtConversion	0	USD
CY2021	us-gaap	Stock Issued1 StockIssued1	34918000	USD
CY2020	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2020	xos	Reverse Recapitalization Transaction Costs ReverseRecapitalizationTransactionCosts	0	USD
CY2021	xos	Debt Conversion Converted Instrument Warrants Issued DebtConversionConvertedInstrumentWarrantsIssued	0	USD
CY2021	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	21540000	USD
CY2020	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	USD
CY2021	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	79708000	USD
CY2020	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	0	USD
CY2021	xos	Noncash Or Part Noncash Acquisition Warrants Assumed NoncashOrPartNoncashAcquisitionWarrantsAssumed	17891000	USD
CY2020	xos	Noncash Or Part Noncash Acquisition Warrants Assumed NoncashOrPartNoncashAcquisitionWarrantsAssumed	0	USD
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1	101744000	USD
CY2020	us-gaap	Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1	0	USD
CY2021	xos	Reverse Recapitalization Transaction Costs ReverseRecapitalizationTransactionCosts	55424000	USD
CY2020	xos	Debt Conversion Converted Instrument Warrants Issued DebtConversionConvertedInstrumentWarrantsIssued	1707000	USD
CY2021	xos	Debt Conversion Converted Instrument Preferred Stock Issued And Stock Options Exercised DebtConversionConvertedInstrumentPreferredStockIssuedAndStockOptionsExercised	0	USD
CY2020	xos	Debt Conversion Converted Instrument Preferred Stock Issued And Stock Options Exercised DebtConversionConvertedInstrumentPreferredStockIssuedAndStockOptionsExercised	2446000	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	The preparation of financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the balance sheet date, as well as reported amounts of revenues and expenses during the reporting periods. The areas with significant estimates and judgments include, among others, contingent Earn-Out shares liability, stock-based compensation, the fair value of the Company’s Common Stock and Preferred Stock, valuation of the convertible notes and the related embedded derivative, SAFE (as defined below), Warrants and warrant liability on Legacy Xos Preferred Stock. Management bases its estimates on historical experience and on various other assumptions believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from those estimates, and such differences could be material to the Company’s financial statements.
CY2021	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Certain prior p</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">eriod balances have been reclassified to conform to the current period presentation in the consolidated financial statements and the accompanying notes, including classification of operating expenses in the consolidated statements of operations and comprehensive income (loss) and other liabilities table in the selected balance sheet data note. The Company reclassified a portion of its payroll related expenses in general and administrative to sales and marketing and research and development. Additionally, the Company reclassified depreciation expense to general and administrative expense. These reclassifications have no effect on previously reported consolidated financial statements.</span>
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2020	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2020Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	0	USD
CY2019Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	0	USD
CY2021	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	0	USD
CY2020	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	0	USD
CY2021	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	177000	USD
CY2020	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	0	USD
CY2021Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	177000	USD
CY2020Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	0	USD
CY2020Q4	xos	Safe Note Percentage Of Price Per Share In Calculation For Conversion Into Temporary Equity SAFENotePercentageOfPricePerShareInCalculationForConversionIntoTemporaryEquity	0.80
CY2020Q4	xos	Simple Agreement For Future Equity Notes Payable Current SimpleAgreementForFutureEquityNotesPayableCurrent	30000	USD
CY2020Q4	xos	Simple Agreement For Future Equity Notes Payable Current SimpleAgreementForFutureEquityNotesPayableCurrent	30000	USD
CY2020Q4	xos	Simple Agreement For Future Equity Notes Payable Current SimpleAgreementForFutureEquityNotesPayableCurrent	30000	USD
CY2021	us-gaap	Revenue Recognition Leases RevenueRecognitionLeases	<div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company accounts for arrangements as a lease under ASC 840, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Leases</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (“ASC 840”), if the arrangement conveys the right to control property, plant, or equipment for a period in exchange for consideration. The Company determines if an arrangement is a lease, or contains a lease, at inception, which is the date the underlying asset is made available for use by the lessor. The Company evaluates all leases for capital or operating classification at their inception. Equipment leases are classified as capital leases, the Company recognizes interest expense associated with the capital lease liability and depreciation expense associated with the capital lease asset. Current portion of the lease liability is based on lease payments due within twelve months of the balance sheet date, and the capital liabilities are increased by interest and reduced by payments each period. The Company’s remaining leases are classified as operating leases. Rent expense is recognized on a straight-line basis over the lease term. The difference between the rent due under the stated periods of the lease compared to that of the straight-line basis is recorded as deferred rent within other current liabilities and other long-term liabilities within the consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The leases have remaining terms from 1 to 6 years.</span></div>
CY2021Q1	xos	Proceeds From The Conversion Of Safe Notes ProceedsFromTheConversionOfSAFENotes	620000	USD
CY2021Q1	xos	Temporary Equity Stock Issued During Period Shares New Issues TemporaryEquityStockIssuedDuringPeriodSharesNewIssues	76471	shares
CY2021	us-gaap	Advertising Expense AdvertisingExpense	378000	USD
CY2020	us-gaap	Advertising Expense AdvertisingExpense	18000	USD
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. As of December 31, 2021 and 2020, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such accounts.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the year ended December 31, 2021, three customers accounted for 10%, 38%, and 46%, respectively of the Company’s revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. During the year ended December 31, 2020, three customers accounted for 11%, 40%, and 49% </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">of the Company’s revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</span></div>
CY2021	xos	Defined Contribution Plan Auto Enrollment Contributions Per Employee Percent DefinedContributionPlanAutoEnrollmentContributionsPerEmployeePercent	0.03
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	0	USD
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	0	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	149500000	USD
CY2021	us-gaap	Other Than Temporary Impairment Loss Debt Securities Available For Sale OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale	0	USD
CY2021	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	161000	USD
CY2020	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	132000	USD
CY2021	us-gaap	Revenues Revenues	5048000	USD
CY2020	us-gaap	Revenues Revenues	2641000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	30900000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	1900000	USD
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	20382000	USD
CY2020Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1289000	USD
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	10659000	USD
CY2020Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	578000	USD
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	901000	USD
CY2020Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	0	USD
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1059000	USD
CY2020Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	0	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	30883000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	1867000	USD
CY2021Q4	xos	Prepaid Inventory PrepaidInventory	7303000	USD
CY2020Q4	xos	Prepaid Inventory PrepaidInventory	8000	USD
CY2021Q4	us-gaap	Prepaid Insurance PrepaidInsurance	4996000	USD
CY2020Q4	us-gaap	Prepaid Insurance PrepaidInsurance	48000	USD
CY2021Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	2783000	USD
CY2020Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	0	USD
CY2021Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	1848000	USD
CY2020Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	USD
CY2021Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	801000	USD
CY2020Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	0	USD
CY2021Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	119000	USD
CY2020Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	0	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	17850000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	56000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3997000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1837000	USD
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	0	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	899000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	731000	USD
CY2021Q4	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	177000	USD
CY2020Q4	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	0	USD
CY2020Q4	us-gaap	Interest Payable Current InterestPayableCurrent	2453000	USD
CY2021Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	306000	USD
CY2020Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	121000	USD
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5379000	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5142000	USD
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q3	xos	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	1.956440
CY2021Q3	xos	Stock Issued During Period Shares Reverse Recapitalization StockIssuedDuringPeriodSharesReverseRecapitalization	142584621	shares
CY2021Q3	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	19600000	shares
CY2021Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10.00
CY2021Q3	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	196000000	USD
CY2021Q3	xos	Sale Of Stock Consideration Not Funded SaleOfStockConsiderationNotFunded	4000000	USD
CY2021Q3	xos	Payments Of Reverse Recapitalization Transaction Costs PaymentsOfReverseRecapitalizationTransactionCosts	44200000	USD
CY2021Q3	xos	Derivative Instrument Contingent Consideration Liability DerivativeInstrumentContingentConsiderationLiability	101700000	USD
CY2021Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	17900000	USD
CY2021	xos	Cash Acquired Through Reverse Recapitalization CashAcquiredThroughReverseRecapitalization	76145000	USD
CY2021	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	196000000	USD
CY2021	xos	Payments Of Reverse Recapitalization Underwriters Fees PaymentsOfReverseRecapitalizationUnderwritersFees	24285000	USD
CY2021	xos	Payments Of Reverse Recapitalization Other Transaction Costs PaymentsOfReverseRecapitalizationOtherTransactionCosts	31139000	USD
CY2021	xos	Reverse Recapitalization Net ReverseRecapitalizationNet	216721000	USD
CY2021	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	19600000	shares
CY2021	xos	Stock Issued During Period Shares Reverse Recapitalization StockIssuedDuringPeriodSharesReverseRecapitalization	162184621	shares
CY2021Q3	xos	Derivative Instrument Contingent Consideration Liability Shares DerivativeInstrumentContingentConsiderationLiabilityShares	16200000	shares
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y2M26D
CY2021	xos	Debt Securities Available For Sale Unrealized Gain Noncurrent DebtSecuritiesAvailableForSaleUnrealizedGainNoncurrent	0	USD
CY2021	xos	Debt Securities Available For Sale Unrealized Loss Noncurrent DebtSecuritiesAvailableForSaleUnrealizedLossNoncurrent	295000	USD
CY2021Q3	xos	Derivative Instrument Contingent Consideration Liability Fair Value Disclosure DerivativeInstrumentContingentConsiderationLiabilityFairValueDisclosure	101700000	USD
CY2021Q4	xos	Derivative Instrument Contingent Consideration Liability DerivativeInstrumentContingentConsiderationLiability	29200000	USD
CY2021	xos	Derivative Instrument Change In Amount Of Contingent Consideration Liability DerivativeInstrumentChangeInAmountOfContingentConsiderationLiability	-72500000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	94782000	USD
CY2021	xos	Debt Securities Available For Sale Unrealized Gain Current DebtSecuritiesAvailableForSaleUnrealizedGainCurrent	1000	USD
CY2021	xos	Debt Securities Available For Sale Unrealized Loss Current DebtSecuritiesAvailableForSaleUnrealizedLossCurrent	87000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	94696000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Noncurrent DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent	55111000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	54816000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	149512000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	381000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	0	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	149512000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	381000	USD
CY2021	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	0	USD
CY2020	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	0	USD
CY2021	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	1000	USD
CY2020	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	0	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	95000	USD
CY2021	xos	Debt Securities Available For Sale Maturity Allocated And Single Maturity Date Weighted Average Contractual Maturity Period DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWeightedAverageContractualMaturityPeriod	P0Y9M18D
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2020Q4	xos	Common Stock Voting Rights Number Of Votes CommonStockVotingRightsNumberOfVotes	1	vote
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	95000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	55000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	55000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis	150000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	150000	USD
CY2021Q4	xos	Capital Stock Shares Authorized CapitalStockSharesAuthorized	1010000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.02
CY2021	xos	Class Of Warrant Or Right Fair Market Value Threshold Consecutive Trading Days Ending On Third Trading Day Prior To Notice Of Redemption ClassOfWarrantOrRightFairMarketValueThresholdConsecutiveTradingDaysEndingOnThirdTradingDayPriorToNoticeOfRedemption	P10D
CY2020Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1	shares
CY2020Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	319411	shares
CY2020Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	8.50
CY2020Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2020Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1700000	USD
CY2021Q3	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	2700000	USD
CY2020Q4	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	6400000	USD
CY2021Q4	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	0	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2671738	shares
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.01
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	561413	shares
CY2021	xos	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue	0.02
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.02
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	27000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.02
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	271566	shares
CY2021	xos	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodWeightedAverageGrantDateFairValue	0.03
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.04
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1838759	shares
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.02
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y2M19D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	5756797	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	482868	shares
CY2021	xos	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableWeightedAverageGrantDateFairValue	0.02
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	5800000	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	4000000	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.02
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y11M26D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1511159	USD
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1700000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	15000	USD
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1658000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	15000	USD
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	6400000	USD
CY2021	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y11M23D
CY2020Q4	xos	Simple Agreement For Future Equity Notes Payable Current SimpleAgreementForFutureEquityNotesPayableCurrent	30000	USD
CY2020Q4	xos	Safe Note Price Per Share In Calculation For Conversion Into Temporary Equity SAFENotePricePerShareInCalculationForConversionIntoTemporaryEquity	30	USD
CY2020Q4	xos	Safe Note Percentage Of Price Per Share In Calculation For Conversion Into Temporary Equity SAFENotePercentageOfPricePerShareInCalculationForConversionIntoTemporaryEquity	0.80
CY2021Q1	xos	Proceeds From The Conversion Of Safe Notes ProceedsFromTheConversionOfSAFENotes	620000	USD
CY2020Q4	xos	Simple Agreement For Future Equity Notes Payable Current SimpleAgreementForFutureEquityNotesPayableCurrent	30000	USD
CY2021Q1	xos	Temporary Equity Stock Issued During Period Shares New Issues TemporaryEquityStockIssuedDuringPeriodSharesNewIssues	76471	shares
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8897000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1761000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1471000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	677000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7426000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1084000	USD
CY2021	us-gaap	Depreciation Depreciation	736000	USD
CY2020	us-gaap	Depreciation Depreciation	296000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	1167000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	1158000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	1192000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	1228000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	1265000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	106000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	6116000	USD
CY2021Q4	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	442000	USD
CY2021Q4	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	386000	USD
CY2021	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	765000	USD
CY2020	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	234000	USD
CY2021Q4	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	482000	USD
CY2021Q4	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	401000	USD
CY2021Q4	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	339000	USD
CY2021Q4	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter	27000	USD
CY2021Q4	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	2077000	USD
CY2021	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	141000	USD
CY2020	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	141000	USD
CY2021Q4	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent	364000	USD
CY2021Q4	xos	Notes Payable Related Parties Interest Rate Stated Percentage NotesPayableRelatedPartiesInterestRateStatedPercentage	0.0238
CY2021Q4	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent	364000	USD
CY2021	xos	Effective Income Tax Rate Reconciliation Adjustments On Convertible Notes Percent EffectiveIncomeTaxRateReconciliationAdjustmentsOnConvertibleNotesPercent	0.1266
CY2020	xos	Notes Payable Related Parties Accrued Interest NotesPayableRelatedPartiesAccruedInterest	15000	USD
CY2021	xos	Number Of Vehicles Acquired From Related Party NumberOfVehiclesAcquiredFromRelatedParty	2	vehicle
CY2021	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	15000	USD
CY2020	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	6500	USD
CY2021	xos	Notes Payable Related Parties Number Of Notes Payable Converted NotesPayableRelatedPartiesNumberOfNotesPayableConverted	34	note_payable
CY2021Q4	xos	Temporary Equity Stock Issued During Period To Related Parties Value Conversion Of Convertible Securities TemporaryEquityStockIssuedDuringPeriodToRelatedPartiesValueConversionOfConvertibleSecurities	18900000	USD
CY2021Q4	xos	Temporary Equity Stock Issued During Period To Related Parties Shares Conversion Of Convertible Securities TemporaryEquityStockIssuedDuringPeriodToRelatedPartiesSharesConversionOfConvertibleSecurities	19664000	USD
CY2021Q4	us-gaap	Due To Employees Current And Noncurrent DueToEmployeesCurrentAndNoncurrent	57000	USD
CY2020Q4	us-gaap	Due To Employees Current And Noncurrent DueToEmployeesCurrentAndNoncurrent	35000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	23403000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-16667000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	0	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	0	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	23403000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16667000	USD
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.0011
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0
CY2021	xos	Effective Income Tax Rate Reconciliation Adjustments On Earnout Interests Liability Percent EffectiveIncomeTaxRateReconciliationAdjustmentsOnEarnoutInterestsLiabilityPercent	-0.6506
CY2020	xos	Effective Income Tax Rate Reconciliation Adjustments On Earnout Interests Liability Percent EffectiveIncomeTaxRateReconciliationAdjustmentsOnEarnoutInterestsLiabilityPercent	0
CY2021	xos	Effective Income Tax Rate Reconciliation Adjustments On Derivative Liability Percent EffectiveIncomeTaxRateReconciliationAdjustmentsOnDerivativeLiabilityPercent	-0.1660
CY2020	xos	Effective Income Tax Rate Reconciliation Adjustments On Derivative Liability Percent EffectiveIncomeTaxRateReconciliationAdjustmentsOnDerivativeLiabilityPercent	0
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0001
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2020	xos	Effective Income Tax Rate Reconciliation Adjustments On Convertible Notes Percent EffectiveIncomeTaxRateReconciliationAdjustmentsOnConvertibleNotesPercent	0
CY2021	xos	Effective Income Tax Rate Reconciliation Transaction Costs Percent EffectiveIncomeTaxRateReconciliationTransactionCostsPercent	-0.2191
CY2020	xos	Effective Income Tax Rate Reconciliation Transaction Costs Percent EffectiveIncomeTaxRateReconciliationTransactionCostsPercent	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.0318
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.2033
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.9200
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.0132
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	18649000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards General Business DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness	1180000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards General Business DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	2376000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	603000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	22808000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	21530000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1278000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1278000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	0	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1278000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	130900000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	21500000	USD
CY2021	xos	Adjustments To Additional Paid In Capital Expected Increase Upon Deferred Tax Valuation Allowance Reversal AdjustmentsToAdditionalPaidInCapitalExpectedIncreaseUponDeferredTaxValuationAllowanceReversal	2400000	USD
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	72027000	shares
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	105568000	shares
CY2021	us-gaap	Net Income Loss NetIncomeLoss	23401000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-16667000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	105568000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	72027000	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.22
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	107786000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	72027000	shares
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.22
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	0	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	0	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	0	USD

Files In Submission

Name	View Source	Status
0001819493-22-000013-index-headers.html	Edgar Link	pending
0001819493-22-000013-index.html	Edgar Link	pending
0001819493-22-000013.txt	Edgar Link	pending
0001819493-22-000013-xbrl.zip	Edgar Link	pending
a202110-kexhibit1013.htm	Edgar Link	pending
a202110-kexhibit1014.htm	Edgar Link	pending
a202110-kexhibit211.htm	Edgar Link	pending
a202110-kexhibit231.htm	Edgar Link	pending
a202110-kexhibit311.htm	Edgar Link	pending
a202110-kexhibit312.htm	Edgar Link	pending
a202110-kexhibit321.htm	Edgar Link	pending
a202110-kexhibit44.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
xos-20211231.htm	Edgar Link	pending
xos-20211231.xsd	Edgar Link	pending
xos-20211231_cal.xml	Edgar Link	unprocessable
xos-20211231_def.xml	Edgar Link	unprocessable
xos-20211231_g1.jpg	Edgar Link	pending
xos-20211231_g2.jpg	Edgar Link	pending
xos-20211231_g3.jpg	Edgar Link	pending
xos-20211231_g4.jpg	Edgar Link	pending
xos-20211231_g5.jpg	Edgar Link	pending
xos-20211231_g6.jpg	Edgar Link	pending
xos-20211231_g7.jpg	Edgar Link	pending
xos-20211231_g8.jpg	Edgar Link	pending
xos-20211231_htm.xml	Edgar Link	completed
xos-20211231_lab.xml	Edgar Link	unprocessable
xos-20211231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$XOS
Xos, Inc. Stock $xos

2021 Q4 Form 10-K Financial Statement

#000181949322000013 Filed on March 30, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XOS Xos, Inc. Stock $xos

2021 Q4 Form 10-K Financial Statement

#000181949322000013 Filed on March 30, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XOS
Xos, Inc. Stock $xos